Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema following Large Hemispheric Infarction

This Study is
No Longer Enrolling

Details
Age

Adult

Type of Study

Treatment

Locations

CTRC Inpatient
Outpatient CTRC
University of Colorado Hospital

Study ID

Protocol Number: 19-0675

More information available at ClinicalTrials.gov: NCT02864953

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers